SRTS official logo SRTS
SRTS 1-star rating from Upturn Advisory
Sensus Healthcare Inc (SRTS) company logo

Sensus Healthcare Inc (SRTS)

Sensus Healthcare Inc (SRTS) 1-star rating from Upturn Advisory
$3.83
Last Close (24-hour delay)
Profit since last BUY-8.81%
upturn advisory logo
WEAK BUY
BUY since 25 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/12/2025: SRTS (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

2 star rating from financial analysts

5 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $7.33

1 Year Target Price $7.33

Analysts Price Target For last 52 week
$7.33 Target price
52w Low $3.03
Current$3.83
52w High $9.08

Analysis of Past Performance

Type Stock
Historic Profit -39.25%
Avg. Invested days 26
Today’s Advisory WEAK BUY
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 62.97M USD
Price to earnings Ratio -
1Y Target Price 7.33
Price to earnings Ratio -
1Y Target Price 7.33
Volume (30-day avg) 5
Beta 1.24
52 Weeks Range 3.03 - 9.08
Updated Date 12/14/2025
52 Weeks Range 3.03 - 9.08
Updated Date 12/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.18

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -8.44%
Operating Margin (TTM) 40.84%

Management Effectiveness

Return on Assets (TTM) -5.75%
Return on Equity (TTM) -5.71%

Valuation

Trailing PE -
Forward PE 21.37
Enterprise Value 38988887
Price to Sales(TTM) 1.77
Enterprise Value 38988887
Price to Sales(TTM) 1.77
Enterprise Value to Revenue 1.09
Enterprise Value to EBITDA 8.68
Shares Outstanding 16425036
Shares Floating 13712575
Shares Outstanding 16425036
Shares Floating 13712575
Percent Insiders 18.01
Percent Institutions 28.73

About Sensus Healthcare Inc

Exchange NASDAQ
Headquaters Boca Raton, FL, United States
IPO Launch date 2016-06-03
Co-Founder, Chairman & CEO Mr. Joseph C. Sardano
Sector Healthcare
Industry Medical Devices
Full time employees 54
Full time employees 54

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.